Shanghai Aohua Photoelectricity Endoscope (688212.SH) issues a profit warning, expecting a net profit of 15.73 million to 23.38 million yuan for the year 2024, a year-on-year decrease of 59.59% to 72.81%.
Australia China Endoscope (688212.SH) issued a notice, the company expects to achieve attributable to owners of the parent company in 2024...
Shanghai Aohua Photoelectric Endoscope (688212.SH) announced that the company expects to achieve a net profit attributable to the owner of the parent company of 15.73 million to 23.38 million in 2024. Compared with the same period last year, it will decrease by 34.4744 million to 42.1244 million, a year-on-year decrease of 59.59% to 72.81%.
Related Articles
HK Stock Market Move | KEYMED BIO-B(02162) rose by over 7%, Goldman Sachs said that Sipokiba monoclonal antibody is expected to lay the foundation for the company's valuation.
Show resilience! European companies are "immune" to US tariffs, and are expected to achieve double-digit profit growth next year.
FIRST SHANGHAI: Maintains "Buy" rating on Zhuzhou CRRC Times Electric (03898) with a target price of 55 Hong Kong dollars.
HK Stock Market Move | KEYMED BIO-B(02162) rose by over 7%, Goldman Sachs said that Sipokiba monoclonal antibody is expected to lay the foundation for the company's valuation.
Show resilience! European companies are "immune" to US tariffs, and are expected to achieve double-digit profit growth next year.
FIRST SHANGHAI: Maintains "Buy" rating on Zhuzhou CRRC Times Electric (03898) with a target price of 55 Hong Kong dollars.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
